Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Eisai (Japan), Japan, covering academic research published from 2000 to 2022. Read More.
Open Access Percentage
48%
Total
Publications
3.5K
Total Open
Publications
1.7K
Total
Citations
105K
Open Access
Percentage
48%
Total
Publications
3.5K
Total Open
Publications
1.7K
Total
Citations
105K
Breakdown
Publisher Open
24%
Both
19%
Other Platform Open
5%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
311
Hybrid 40%
607
No Guarantees 39%
595
Other Platform Open
Domain 86%
721
Institution 22%
187
Public 10%
84
Other Internet 8%
65
Preprint 2%
18
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 720 |
Europe PMC | Domain | 492 |
Figshare | Public | 63 |
DOI | Other Internet | 61 |
University College London - UCL Discovery | Institution | 55 |
Semantic Scholar | Public | 54 |
bioRxiv | Preprint | 14 |
The University of Glasgow - Enlighten: Publications | Institution | 12 |
University of California - eScholarship University of California | Institution | 11 |
Le Centre pour la Communication Scientifique Directe - HAL - memSIC | Other Internet | 10 |